We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 5.84% | 7.25 | 7.00 | 7.50 | 7.25 | 6.85 | 6.85 | 1,554,889 | 16:18:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.11 | 43.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/8/2022 07:20 | LOSS OF A WHOPPING £6.1m. BUT READ THIS !!! THEY HAVE THE OUTRIGHT CHUTZPAH TO SAY THAT THERE IS A BIG JUMP IN REVENUES:- "Our revenues grew by 16% compared to the previous year as we saw increased commercial traction, particularly in the CBRN segment, and ended the year in a better position than we began it." But that's not all it appears in my view £1.4million of their REVENUES is OTHER INCOME which is moneyfrom UK and US government which they count as REVENUES - and they say that REVENUES are strongly ahead - but by no means all from commercial activities . This is the real contributory reason for the apparent jump in revenues "Other Income The Group generated total other operating income of GBP1.4m (2021: GBP0.4m), which predominantly comprises the forgiveness of Paycheck Protection Programme (PPP) loans in the US. The Group had been granted PPP loans totalling US$1.8m (GBP1.4m) in the prior year and, during the period under review, applied for, and received, forgiveness for repayment from the US Government. In the prior year period, GBP0.3m of the GBP0.4m of other operating income comprised UK Government grants in response to COVID-19. The balance of remaining other operating income relates to grants received from the Coronavirus Job Retention Scheme provided by the UK Government in response to COVID-19's economic impact on businesses and other small miscellaneous grants." ALL IMO. DYOR. QP | quepassa | |
29/7/2022 13:20 | The biological pathogen detector technology clearly works after winning prizes from the institute of physics, getting an accreditation and a nato innovation award. Why there’s no update is perplexing. I fortunately reduced my holding at 16p where it was 10% of my portfolio and still hold a small amount (2% of portfolio). I feel there could well be a significant government order in the next year. Governments can be very slow moving and we were advised by the ceo they were in “serious discussions with multiple governments”. Definitely a high risk investment in my opinion, but still a little hope left here. I think that view represents the market opinion of Kromek. Could well be further losses if history is to repeat itself in the meantime. While significant share price gains could materialise should an order come through - the ceo spoke of multi-billion pound fees to network a country with the devices - analysts seem to be of the opinion Kromek are due to make a small profit at the next results. While the tie up with Smiths detection was promising I’ve no idea in reality what’s going on with this share, but I believe it’s worth a small gamble still. I think the current valuation is fair until there’s some news. Could drop to 4p if further losses and no new sales are announced - while I believe it could reach 50p with some biological pathogen detector sales. | aqc888 | |
29/7/2022 09:06 | Nail on the head,QuePassa. | b00mb0y | |
29/7/2022 08:08 | Kromek. Talk-the-Talk 10/10 Walk-the-Talk 0/10 all imo. dyor. qp | quepassa | |
27/7/2022 00:34 | No offence buddy , but this works better | 2trying | |
26/7/2022 19:34 | hxxps://www.thisisar | strategicinvestor2 | |
21/7/2022 11:34 | No but I'd like to see what spin Simon Thompson puts on them | estienne | |
19/7/2022 12:42 | Year end results - anyone got news or contacted company for an update ? | strategicinvestor2 | |
14/7/2022 01:35 | QuePassa - The prospect of Covid detector ever making significant profits has surely now vanished?? Not even the biggest bulls here would have ever guessed in a million years still no proper update or sales half way through July 2022.It's really remarkable actually considering the Basu hype job and money raised. | ark87 | |
13/7/2022 20:23 | It seems that local governments only spend any reasonable manpower resource is for preventing Legionella pneumophila. An inexpensive, autonomous system that could do this might find application in hundreds of sites, such as swimming pools in a particular region. Legionella is becoming particularly interesting with rising temperatures and the ineffectiveness of usual chlorination protocols. All IMO | simithy | |
13/7/2022 16:23 | So what happened to all the pathogen detectors for covid which were going to rolled out and installed on literally every street corner throughout the entire nation? Personally, I haven't seen or heard of a single one in any public space such as a shopping centre, train station, cinema, waiting room, work-place, health club, stadium, airport, school or office block. Has anyone seen a covid/other airborne pathogen detector in any place? ALL IMO. DYOR. QP | quepassa | |
07/7/2022 14:34 | They turn over £2.4bn so significant to update on Kromek. Wonder if they will have further interest in Kromek ? | strategicinvestor2 | |
07/7/2022 14:04 | Smiths Detection have out their own Press Release out, so you can read what their President says about the KMK agreement below. Quite a lot of important recent previous press releases there too... | edmonda | |
07/7/2022 12:40 | Suspect they see as the world leading product streets ahead of anythiNg else as recently endorsed independently … | strategicinvestor2 | |
07/7/2022 12:30 | Harold - not saying it's happening here, but if they have a competitor product, they might effectively kill kmk's product in the States in favour of their own. In any case, it's likely that their salespeople will have higher bonus on own product vs 3rd-party equivalent, and you can guess where that leads. | supernumerary | |
07/7/2022 11:24 | Yep, this is really good news. And very welcome too!! | dougmachin | |
07/7/2022 11:21 | When are final results released ? Cheers | strategicinvestor2 | |
07/7/2022 11:16 | i hope you are right but lots of distributors try all sorts of new product lines all the time - that doesn't mean to say they will sell and smiths are not saying that they are, for example, stocking/buying 1,000 pieces of kit for onward sale because they know they could sell them. all imo. dyor. qp | quepassa | |
07/7/2022 11:12 | Fantastic news - can only be viewed as a positive and hopefully a lot more newsflow. iMHO DYOR | strategicinvestor2 | |
07/7/2022 10:55 | Why would smiths get involved if they thought the product had no future ? It is a better signal than executives saying we have a brilliant product . IMHO | haroldthegreat | |
07/7/2022 09:02 | that's not a contract. that's a distribution agreement. zero concrete information on when it commences/how long it lasts/how many units are covered/rate of commissions/ it doesn't say that smiths are committing to buy any - nor does it give any idea about anticipated sales. i hope this distribution agreement performs better than the manufacturing under license agreement with Metran on the ventilators. all imo. dyor. qp | quepassa | |
07/7/2022 08:50 | Would Smith's get involved with a rubbish product ? I don't think so ! | haroldthegreat | |
07/7/2022 07:30 | contracts rns | ali47fish |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions